Your browser doesn't support javascript.
loading
SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1.
Altamura, Sandro; Schaeper, Ute; Dames, Sibylle; Löffler, Kathrin; Eisermann, Mona; Frauendorf, Christian; Müdder, Katja; Neves, Joana; Muckenthaler, Martina U.
Affiliation
  • Altamura S; Department of Pediatric Hematology, Oncology and Immunology - University of Heidelberg, Germany.
  • Schaeper U; Molecular Medicine Partnership Unit, Heidelberg, Germany.
  • Dames S; Silence Therapeutics GmbH, Berlin, Germany.
  • Löffler K; Silence Therapeutics GmbH, Berlin, Germany.
  • Eisermann M; Silence Therapeutics GmbH, Berlin, Germany.
  • Frauendorf C; Silence Therapeutics GmbH, Berlin, Germany.
  • Müdder K; Silence Therapeutics GmbH, Berlin, Germany.
  • Neves J; Department of Pediatric Hematology, Oncology and Immunology - University of Heidelberg, Germany.
  • Muckenthaler MU; Molecular Medicine Partnership Unit, Heidelberg, Germany.
Hemasphere ; 3(6): e301, 2019 12.
Article in En | MEDLINE | ID: mdl-31976476

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2019 Document type: Article Affiliation country: Germany Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2019 Document type: Article Affiliation country: Germany Country of publication: United States